3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Hyponatremia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Hyponatremia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, CA; Hsueh, CJ; Huang, WS; Lee, JT; Lin, CC; Peng, GS; Wu, YC	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Hyponatremia

Article	Year
(99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features. Annals of nuclear medicine, 2009, Volume: 23, Issue:4 Topics: Benzamides; Dopamine; Female; Humans; Hyponatremia; Middle Aged; Myelinolysis, Central Pontine; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes	2009

Article

Year

(99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.

Annals of nuclear medicine, 2009, Volume: 23, Issue:4

Topics: Benzamides; Dopamine; Female; Humans; Hyponatremia; Middle Aged; Myelinolysis, Central Pontine; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes

2009